Expression of alpha smooth muscle actin in living donor liver transplant recipients

被引:0
|
作者
Masataka Hirabaru [1 ]
Kyoko Mochizuki [1 ]
Mitsuhisa Takatsuki [1 ]
Akihiko Soyama [1 ]
Taiichiro Kosaka [1 ]
Tamotsu Kuroki [1 ]
Isao Shimokawa [2 ]
Susmu Eguchi [1 ]
机构
[1] Department of Surgery,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,Japan
[2] Department of Investigative Pathology,Nagasaki University Graduate School of Biomedical Sciences,Nagasaki 852-8501,Japan
关键词
Living donor liver transplantation; Liver fibrosis; Immunosuppressant therapy; Alpha smooth muscle actin; Hepatic stellate cells;
D O I
暂无
中图分类号
R657.3 [肝及肝管];
学科分类号
1002 ; 100210 ;
摘要
Recently,there have been reports from liver biopsies that showed the progression of liver fibrosis in liver transplant patients after the cessation of immunosuppression.Herein,we focused on activated hepatic stellate cells expressing alpha smooth muscle actin(α-SMA)to understand the correlation between immunosuppressant medication and liver fibrosis.The study enrolled two pediatric patients who underwent living donor liver transplantation and ceased immunosuppressant therapy.The number ofα-SMA-positive cells in the specimens obtained by liver biopsy from these two patients showed a three-fold increase compared with the number from four transplanted pediatric patients who were continuing immunosuppressant therapy.In addition,theα-SMA-positive area evaluated using the WinRooF image processing software program continued toincrease over time in three adult transplanted patients with liver fibrosis,and theα-SMA-positive area was increasing even during the pre-fibrotic stage in these adult cases,according to a retrospective review.Therefore,α-SMA could be a useful marker for the detection of early stage fibrosis.
引用
收藏
页码:7067 / 7074
页数:8
相关论文
共 50 条
  • [41] Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients
    Taber, DJ
    Dupuis, RE
    Fann, AL
    Andreoni, KA
    Gerber, DA
    Fair, JH
    Johnson, MW
    Shrestha, R
    LIVER TRANSPLANTATION, 2002, 8 (03) : 219 - 223
  • [42] ALTERED ALPHA-SMOOTH MUSCLE ACTIN EXPRESSION IN HIRSCHPRUNGS DISEASE
    FROMONTHANKARD, G
    LAFER, D
    MASOOD, S
    LABORATORY INVESTIGATION, 1995, 72 (01) : A61 - A61
  • [43] Cholestatic hepatitis C in living versus deceased donor liver transplant recipients
    Gaglio, Paul J.
    Verna, Elizabeth C.
    DeMartin, Eleonora
    LaPointe-Rudow, Dianne
    Lefkowitch, Jay
    Renz, John
    Emond, Jean
    Brown, Robert S.
    HEPATOLOGY, 2006, 44 (04) : 429A - 429A
  • [44] CYCLOSPORINE DISPOSITION IN LIVING RELATED DONOR PARTIAL LIVER-TRANSPLANT RECIPIENTS
    TADA, A
    TSUBOUCHI, S
    ZENDA, H
    MATSUNAMI, H
    IKEGAMI, T
    HASHIKURA, Y
    KITAHARA, S
    TERADA, M
    ISHIZONE, S
    KAWASAKI, S
    MAKUUCHI, M
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1993, 113 (01): : 84 - 93
  • [45] Outcomes of living and deceased donor liver transplant recipients according to the MELD score
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Song, Seung Hwan
    Lee, Jee Youn
    Kwon, Su-Kyung
    Joo, Dong Jin
    Ju, Man Ki
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    Kim, Myoung Soo
    TRANSPLANTATION, 2016, 100 (07) : S511 - S512
  • [46] INDUCTION OF ALPHA SMOOTH-MUSCLE ACTIN EXPRESSION IN CULTURED FIBROBLASTS
    THAPAR, N
    ROCHE, WR
    JOURNAL OF PATHOLOGY, 1992, 168 : A97 - A97
  • [47] SERIAL CHANGE OF NUTRITIONAL AND METABOLIC STATUS IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS
    Shimada, Mitsuo
    Ikegami, Toru
    Imura, Satoru
    Morine, Yuji
    Kanemura, Hirofomi
    Nii, Akira
    Takeuchi, Harumi
    Takeda, Eiji
    LIVER TRANSPLANTATION, 2008, 14 (07) : S132 - S133
  • [48] Zygomycosis in Living Donor Liver Transplant Recipients: A Single Centre Experience.
    Srivastava, Manish
    Mehta, Naimish
    Varma, Vibha
    Kapoor, Sorabh
    Nundy, Samiran
    Kumaran, Vinay
    LIVER TRANSPLANTATION, 2013, 19 : S247 - S248
  • [49] Intraoperative fluid management of living donor versus cadaveric liver transplant recipients
    Niemann, CU
    Hirose, R
    Stock, P
    Roberts, JP
    Mandell, S
    Yost, CS
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (05) : 1466 - 1468
  • [50] Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients
    Azam, Fahad
    Khan, Moosa
    Bhatti, Abu Bakar Hafeez
    Dar, Faisal Saud
    Ahmad, Arsalan
    Javed, Nismat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (11): : 1048 - 1052